5 Stocks To Buy That Pay A 5% Dividend Yield

BP plc (LON:BP), Centrica PLC (LON:CNA), GlaxoSmithKline plc (LON:GSK), Royal Dutch Shell Plc (LON:RDSB) and Vodafone Group Plc (LON:VOD) all yield more than 10 times today’s base rate

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I still can’t get over the fact that solid FTSE 100 players like BP (LSE: BP), Centrica (LSE: CNA), GlaxoSmithKline (LSE: GSK), Royal Dutch Shell (LSE: RDSB) and Vodafone (LSE: VOD) all now yield 5% or more… while cash gives savers a near-zero return!

Too many savers fail to realise how much income they could generate by taking a bit of extra risk with their money, plus the scope for capital growth as well. 

So which of these five stocks are your best income options?

BP

The plummeting oil price has hit BP, whose shares are down 12% in just three months. But that’s good news for income seekers, because a lower share price means a higher yield. Today, you get a juicy 5.3%.

This is riskier than leaving your money in the bank, with Deepwater Horizon legal wrangles dragging on interminably, and BP’s 20% stake in Kremlin-controlled oil enterprise Rosneft succumbing to sanctions.

If you can accept these risks, today’s valuation of just 5.6 times earnings may be a good entry point for long-term investors.

Centrica

British Gas owner Centrica offers an even more generous income of 5.8% a year. Again, a falling share price has helped, with the stock down 17% in the last year, over fears that Labour leader Ed Miliband will punish utility companies if he wins next May’s election.

But these fears are priced in, with Centrica trading at 11 times earnings, and its electric income will keep savers warm this winter.

GlaxoSmithKline

Pharmaceutical giant GlaxoSmithKline is yet another FTSE 100 income hero to stumble, its share price down 15% in six months on the Chinese bribery scandal and falling sales.

Today’s price of 12.6 times earnings looks tempting, especially since it secures you an income of 5.5% a year. And there is scope for capital growth, with profits set to flow from its R&D pipeline.

Royal Dutch Shell

Anglo-Dutch oil major Royal Dutch Shell has had a less turbulent year than BP, yet its share price is still down 9% in three months, largely on the oil price slide.

Shell is more expensive than BP, at 14 times earnings, and its dividend is slightly lower at 5%. But it pumps out cash, posting a $6.1bn profit in the second quarter alone, and looks a lot less risky than its rival right now.

Vodafone

Telecommunications giant Vodafone is another UK blue-chip going cheap, down more than 9% in six months. This really is a great time to go shopping for stocks.

Vodafone is throwing off enough cash to splurge $19 billion on its Project Spring revamp, but still has enough left over to pay you a generous income of 5.52% a year.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Down 15% and a yield of 7.9%! Is this REIT dividend champion now irresistible?

This real estate investment trust (REIT) has one of the highest dividend yields on the London Stock Market. Royston Wild…

Read more »

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Down 32% and with a P/E of 9.5, is this FTSE 250 share too cheap to ignore?

This FTSE 250 share is in freefall after slashing guidance for this financial year. But Royston Wild eyes a potential…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Growth Shares

Why high oil prices could be good news for Lloyds shares

Jon Smith talks through the implications of elevated oil prices and translates that through to the potential impact on Lloyds'…

Read more »

Investing Articles

Lists of income stocks to buy almost never include this one — but with a forecast 8.2% yield, I think they should!

This FTSE firm, not always seen as an income play, has a forecast yield of 8.2%, underlining why it's one…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Aviva’s share price is down 13% to under £7, despite outstanding 2025 results! Time for me to buy more?

I think Aviva’s share price reflects an outdated view of the business, and that gap between perception and reality is…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Shell’s £33+ share price is near an all-time high, so why am I going to buy more as soon as possible?

Shell's strong cash generation and improving growth drivers contrast with a share price well below my valuation, suggesting major long‑term…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

An 8.4% forecast yield but down 16%! Time for me to buy more of this FTSE 100 passive income star?

This FTSE 100 passive‑income machine is delivering rising payouts and strong forecasts, and its share price suggests the market hasn’t…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

£10,000 invested in Meta Platforms Stock 5 years ago is now worth…

Meta Platforms has been throwing good money after bad at Reality Labs since 2021, but the stock has more than…

Read more »